Organogenesis Holdings Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Organogenesis Holdings Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q2 2024.
  • Organogenesis Holdings Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 133M shares, a 0.37% decline year-over-year.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 133M shares, a 0.28% increase from 2022.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 132M shares, a 0.96% decline from 2021.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 134M shares, a 20% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 133M -493K -0.37% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 132M +778K +0.59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 133M +364K +0.28% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 133M +1.18M +0.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 133M +465K +0.35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 131M +2.3M +1.78% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 132M -1.28M -0.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 132M -1.62M -1.21% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 133M -1.39M -1.04% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 129M -4.66M -3.49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 134M +22.3M +20% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 134M +25.4M +23.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 134M +29.3M +28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 133M +29M +27.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 111M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 108M +16.2M +17.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 105M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 104M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 92.3M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q4 2017 64.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 64M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 64M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 66.7M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.